Obalon Therapeutics Inc (OBLN):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Obalon Therapeutics Inc (OBLN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6530
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Obalon Therapeutics Inc (Obalon Therapeutics) is a manufacturer of medical devices and equipment. The company offers development and commercializing medical devices to treat obese and overweight people by facilitating weight loss. It also researches, designs, produces, and sells medical gastric balloon for weight loss therapy. Obalon Therapeutics’ Obalon Balloon System is a swallowable intragastric balloon system indicated for temporary use to facilitate weight loss in adults with obesity. The company’s Obalon balloon system is also designed to provide weight loss in obese patients with combined with diet and exercise. It offers its products through its distributors located across the US, Obalon Therapeutics is headquartered in Carlsbad, California, the US.

Obalon Therapeutics Inc (OBLN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Obalon Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Obalon Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Obalon Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Obalon Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Obalon Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Obalon Therapeutics Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Obalon Therapeutics Raises USD20 Million in Series D Financing 10
Obalon Therapeutics Secures USD10 Million from Square 1 Bank 12
Obalon Therapeutics Raises USD16 Million in Venture Financing 13
Obalon Therapeutics Raises US$5 Million In Venture Financing 14
Obalon Therapeutics Raises US$16.5 Million In Series C Financing 15
Obalon Therapeutics Raises US$1.5 Million In Venture Financing 16
Equity Offering 17
Obalon Therapeutics Plans to Raise Funds through Public Offering of Shares 17
Obalon Therapeutics Raises USD10 Million in Private Placement of Shares 18
Obalon Therapeutics Terminates Public Offering of Shares for USD30 Million 20
Obalon Therapeutics Prices IPO for USD75 Million 22
Obalon Therapeutics Inc – Key Competitors 24
Obalon Therapeutics Inc – Key Employees 25
Obalon Therapeutics Inc – Locations And Subsidiaries 26
Head Office 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Obalon Therapeutics Inc, Medical Equipment, Key Facts, 2017 2
Obalon Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Obalon Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Obalon Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Obalon Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Obalon Therapeutics Inc, Deals By Market, 2012 to YTD 2018 8
Obalon Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Obalon Therapeutics Raises USD20 Million in Series D Financing 10
Obalon Therapeutics Secures USD10 Million from Square 1 Bank 12
Obalon Therapeutics Raises USD16 Million in Venture Financing 13
Obalon Therapeutics Raises US$5 Million In Venture Financing 14
Obalon Therapeutics Raises US$16.5 Million In Series C Financing 15
Obalon Therapeutics Raises US$1.5 Million In Venture Financing 16
Obalon Therapeutics Plans to Raise Funds through Public Offering of Shares 17
Obalon Therapeutics Raises USD10 Million in Private Placement of Shares 18
Obalon Therapeutics Terminates Public Offering of Shares for USD30 Million 20
Obalon Therapeutics Prices IPO for USD75 Million 22
Obalon Therapeutics Inc, Key Competitors 24
Obalon Therapeutics Inc, Key Employees 25

List of Figures
Obalon Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Obalon Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Obalon Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Obalon Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Obalon Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Obalon Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Obalon Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Obalon Therapeutics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Obalon Therapeutics Inc (OBLN):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Emirates NBD Bank:企業の戦略・SWOT・財務分析
    Emirates NBD Bank - Strategy, SWOT and Corporate Finance Report Summary Emirates NBD Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Exact Sciences Corp (EXAS)-医療機器分野:企業M&A・提携分析
    Summary Exact Sciences Corp (Exact) is a molecular diagnostic company that focuses on the early detection and prevention of various cancers. The company’s flagship product, Cologuard test is a non-invasive stool-based deoxyribonucleic acid (DNA) screening product indicated for the early detection of …
  • Transport for London:企業の戦略的SWOT分析
    Transport for London - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • The Hain Celestial Group Inc (HAIN):企業の財務・戦略的SWOT分析
    The Hain Celestial Group Inc (HAIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Nanobiotix SA (NANO):企業の財務・戦略的SWOT分析
    Summary Nanobiotix SA (Nanobiotix) is a late stage clinical company which develops nanomedicines for the treatment of cancers. The company develops first-in-class products utilizing its proprietary technology NanoXray, based on the physical mode of action of nanoparticles that increase the X-rays do …
  • Euro India Fresh Foods Ltd (EIFFL):企業の財務・戦略的SWOT分析
    Euro India Fresh Foods Ltd (EIFFL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Micromedic Technologies Ltd (MCTC):医療機器:M&Aディール及び事業提携情報
    Summary Micromedic Technologies Ltd (Micromedic) is a medical device company that develops and manufactures in vitro cancer diagnostic products and solutions. The company offers products such as histo-chemical platform, genetic assays for personalized medicine and molecular biomarker assays. It prov …
  • Kallpa Generacion SA:企業の戦略的SWOT分析
    Kallpa Generacion SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Pakistan Refinery Ltd (PRL):企業の財務・戦略的SWOT分析
    Pakistan Refinery Ltd (PRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Promimic AB-医療機器分野:企業M&A・提携分析
    Summary Promimic AB (Promimic) is a biomaterial company that develops and markets implant surface modifications and synthetic bones. The company’s products comprise metals, ceramics, polymers, porous materials and pyrocarbon. Its HA-nano surface is a coating based on nanocrystalline hydroxyapatite p …
  • Metanomics Health GmbH:企業の製品パイプライン分析2018
    Summary Metanomics Health GmbH (Metanomics), a subsidiary of BASF SE, is a biotech company that provides metabolic biomarker identification and validation solutions. The company offers analysis of metabolites for various applications in pharma and biotech, biobanking, academia, food and feed industr …
  • Gasum Oy:石油・ガス:M&Aディール及び事業提携情報
    Summary Gasum Oy (Gasum), a subsidiary of Gasonia Oy is an oil and gas company that offers natural gas trading services. The company provides biogas and natural gas for use as a transport fuel, energy production, liquefied natural gas, shipping fuel, and natural gas for electricity and district heat …
  • Sao Martinho SA (SMTO3):企業の財務・戦略的SWOT分析
    Sao Martinho SA (SMTO3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • BioLineRx Ltd (BLRX):企業の財務・戦略的SWOT分析
    BioLineRx Ltd (BLRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • ASCO Group Ltd-石油・ガス分野:企業M&A・提携分析
    Summary ASCO Group Limited (ASCO) is a provider of supply chain management services to the global oil and gas sector and other related industries. The company offers a broad range of services covering logistics, fuels and lubricants, freight forwarding and environmental and waste management services …
  • Teledyne Technologies Incorporated:企業の戦略・SWOT・財務情報
    Teledyne Technologies Incorporated - Strategy, SWOT and Corporate Finance Report Summary Teledyne Technologies Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Neurotez Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Neurotez Inc (Neurotez) is a biotechnology company that develops and markets leptin product, a novel hormone replacement therapy for Alzheimer’s disease (AD). The company's product pipeline includes leptin, NT1, NT2, and others. Its product leptin is an adipocyte hormone that controls energy …
  • Hitachi Construction Machinery Co., Ltd. (6305):企業の財務・戦略的SWOT分析
    Hitachi Construction Machinery Co., Ltd. (6305) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • Vikas WSP Ltd (VIKASWSP):企業の財務・戦略的SWOT分析
    Vikas WSP Ltd (VIKASWSP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Quantum Genomics SA (ALQGC):企業の財務・戦略的SWOT分析
    Summary Quantum Genomics SA (Quantum Genomics) is a bio pharmaceutical company which develops novel medicines in the field of cardiovascular diseases. The company develops drugs to treat high blood pressure and heart failure. Its research programs are based on the Brain Aminopeptidase A Inhibition ( …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆